Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-02-21
1988-06-14
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548453, A61K 3140, C07D48706
Patent
active
047512326
ABSTRACT:
A novel pyrrolizidine derivative of the formula, ##STR1## which has potent antiarrhythmic activity and low toxicity is produced. The derivative can be synthesized: by acylating 2,6-xylidine to protect the amino group, nitrating the protected xylidine to introduce a nitro group at 3-position, reducing the nitro group to an amino group, followed by diazotizing and hydrolyzing, and then the resulted 3-hydroxy-2,6-dimethylaniline being condensed with 8-halocarbonylmethylpyrrolizidine; or by nitrating N-(2',6'-dimethyl)phenyl-8-pyrrolizidineacetamide to introduce a nitro group at 3'-position, reducing the nitro group to amino group, diazotizing the amino group and hydrolyzing the diazonium compound.
REFERENCES:
patent: 4213983 (1980-07-01), Hadley et al.
patent: 4564624 (1986-01-01), Miyano et al.
Ishihara Takafumi
Satoh Fumio
Shima Keiyu
Hollrah Glennon H.
Springer D. B.
Suntory Limited
LandOfFree
Pyrrolizidine derivative and pharmaceutical composition thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolizidine derivative and pharmaceutical composition thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolizidine derivative and pharmaceutical composition thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505307